The largest database of trusted experimental protocols

4 protocols using lispro

1

Insulin Standards and Analogs Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chemicals such as acetonitrile, glacial acetic acid, dimethylsulfoxide, formic acid, methanol, ammonium hydroxide, porcine insulin, bovine insulin, and [[13C6] Leu26, 30]-C-peptide (human) were obtained from Sigma (Schnelldorf, Germany). All aqueous buffers and solutions were prepared in purified water (MilliQ quality, Frankfurt, Germany). Recombinant human insulin was obtained from Aventis (Frankfurt, Germany). The labeled insulin (internal) standard [[2H10] LeuB6, B11, B15, B17]-insulin (human) was purchased from PeptaNova (Sandhausen, Germany). The used solid-phase extraction cartridges OASIS MCX (30 mg, 3 mL) were from Waters (Eschborn, Germany), and the synthetic insulin analogs lispro (Humalog), aspart (Novorapid), glulisine (Apidra), and insulin degludec (Tresiba) were supplied by Eli Lilly (Indianapolis, IN, USA), Novo Nordisk (Princeton, NJ, USA), and Aventis (Kansas City, MO, USA), respectively. The glargine metabolite (DesB31-32 glargine) was obtained from IBA (Warsaw, Poland).
+ Open protocol
+ Expand
2

Hepatic Insulin Signaling Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
After 4 weeks of GluOC treatment, mice were first fasted overnight and then anesthetized by intraperitoneal injection of 1% sodium pentobarbital (0.1 mL/10 g). Five animals in each group were randomly selected and injected with quick-acting insulin (Lispro, Eli Lilly and Co., Indianapolis, Indiana, USA) 1 U/kg into the inferior vena cava, and the liver was separated 3 min after insulin injection and immediately frozen in liquid nitrogen. The other five mice underwent the same sham operation without insulin injection. Livers were homogenized in ice-cold RIPA lysis buffer [50 mM Tris-HCl, 150 mM NaCl, 1% NP-40, 0.1% SDS, protease inhibitor cocktail, and PhosSTOP at pH 7.4 (Roche, Basel, Switzerland)]. Western blot was conducted to detect the expression of proteins related to hepatic insulin and glucose metabolism pathways as previously described [25 (link)]. The images were acquired on a Tanon-5200 Chemiluminescent Imaging System (Tanon Science & Technology, Shanghai, China).
+ Open protocol
+ Expand
3

Ferret Hyperglycemia-Hypoglycemia Hormonal Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
Procedures were established to assess the hormonal responses to the sudden transition from hyperglycemia to hypoglycemia. At 120 minutes during the hyperglycemic clamp, a portion of the ferrets were continued on hyperglycemic infusion, whereas another portion of the ferrets underwent a hypoglycemic phase. In this group of ferrets, the glucose infusion was discontinued at 120 minutes and a continuous infusion of 20 mU/kg/min insulin lispro (Eli Lilly) initiated with an additional 50 mU/kg infused during the initial 5 minutes. insulin lispro does not cross-react with several assays that detect ferret insulin, as detailed in Results. As hypoglycemia ensued, the variable dextrose infusion was resumed with the goal of clamping the blood glucose at 45 mg/dL. The glycemic goal was based on extrapolation from human studies [29] (link) as a glucose level likely to influence islet secretion but avoid hypoglycemia severe enough to risk ferret morbidity. Blood samples (100 µl) were obtained at 120, 125, 130, 150 and 180 min for determination of plasma hormonal concentrations including ferret insulin.
+ Open protocol
+ Expand
4

Insulin Detemir Expiry Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Insulin detemir (IDet), trademarked as Levemir® and manufactured by Novo Nordisk, was obtained as 3 mL vials, 100U/mL (14.2 mg/mL), for FlexTouch® pens, as a gift from the Independent Diabetes Trust. IDet excipients list includes 65.4 μg/mL zinc, 2.06 mg/mL m-cresol, 16.0 mg/mL glycerol, 1.80 mg/mL phenol, 0.89 mg/mL Na 2 HPO 4 •2H 2 O and 1.17 mg/mL NaCl. HCl and NaOH may have been added by the manufacturer to adjust pH to 7.4 [20] . These preparations included expired samples (2013, 2015, 2016, 2017) as well as an in-date batch (2020). While not in use, all IDet preparations were refrigerated at ~5 °C. All experiments involving expiry of samples were carried out over a 4 month period in Summer 2018.
Eight other in-date insulins were also screened to assess temperature dependence, but only for single dose concentrations. These were Human Recombinant (Novorapid®, Novo Nordisk), Bovine and Porcine (Hypurin®, Wockhardt), Aspart (Actrapid®, Novo Nordisk), Glulisine (Apidra®, Sanofi), Lispro (Humalog®, Lilly), Glargine (Lantus®, Sanofi) and Degludec (Tresiba®, Novo Nordisk).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!